Structure Therapeutics Inc. American Depositary Shares (GPCR) Stock Price, Quote & AI Analysis
Live GPCR stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Structure Therapeutics Inc. American Depositary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for Structure Therapeutics Inc. American Depositary Shares (GPCR), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Structure Therapeutics Inc. American Depositary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Structure Therapeutics Inc. American Depositary Shares Overview
Company information
Company Overview
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Structure Therapeutics Inc. American Depositary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...